Neuland gains; brokers say re-rating candidate

Reuters Market Eye - * Neuland Laboratories
* Brokers say the pharma ingredient player is a strong re-rating candidate.
* Emkay says can generate very strong returns in two years.
* Neuland's earnings can grow at a compounded rate of 25 percent, adds Emkay.
* Trades at 8.7 times of 12-month forward earnings versus peer average of 41.78 times.
(Reporting by Abhishek Vishnoi)
More From This Section
Don't miss the most important news and views of the day. Get them on our Telegram channel
First Published: Sep 11 2014 | 10:26 AM IST
